Revised SPCs: Myalepta (metreleptin) powder for solution for injection (all strengths)

SPC now notes that autoimmune disorder progression/flares have been observed in some patients; a causal relationship has not been established but close monitoring is recommended and the benefits and risks of use in patients with autoimmune diseases should be carefully considered.

electronic Medicines compendium